SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001047469-10-005900
Filing Date
2010-06-14
Accepted
2010-06-14 09:25:22
Documents
9
Period of Report
2010-06-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a2199100z8-k.htm 8-K 18318
2 EXHIBIT 23 a2199100zex-23.htm EX-23 3328
3 EXHIBIT 99 a2199100zex-99.htm EX-99 1243686
  Complete submission text file 0001047469-10-005900.txt   5860937

Data Files

Seq Description Document Type Size
4 EX-101.INS genz-20091231.xml EX-101.INS 1325693
5 EX-101.SCH genz-20091231.xsd EX-101.SCH 22616
6 EX-101.CAL genz-20091231_cal.xml EX-101.CAL 69616
7 EX-101.DEF genz-20091231_def.xml EX-101.DEF 21598
8 EX-101.LAB genz-20091231_lab.xml EX-101.LAB 335020
9 EX-101.PRE genz-20091231_pre.xml EX-101.PRE 155286
Mailing Address 500 KENDALL STREET CAMBRIDGE MA 02142
Business Address 500 KENDALL STREET CAMBRIDGE MA 02142 6172527500
GENZYME CORP (Filer) CIK: 0000732485 (see all company filings)

IRS No.: 061047163 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-14680 | Film No.: 10893817
SIC: 2836 Biological Products, (No Diagnostic Substances)